Background: Soluble forms of progenitor cell receptors may be implicated in the delayed erythropoietic response during severe anemia. In this study, plasma levels of soluble erythropoietin receptor (sEPO-R) and soluble granulocyte, macrophage-colony stimulating factor receptor (sGM-CSFR) were assessed in infected children in Ghana.
Methods: This case-control study was conducted at Tamale Teaching Hospital, Ghana. One hundred and twenty infected, and 60 uninfected children aged 12-144 months were recruited from April to July, 2023. About 4 mL of blood was collected for malaria microscopy, full blood count using a haematology analyser, and sEPO-R, sGM-CSFR and erythropoietin (EPO) estimation using enzyme-linked immunosorbent assays. Data were analyzed using SPSS version 26.0.
Results: Plasma levels of sEPO-R were higher among participants with severe malarial anemia (SMA) than those in the non-SMA and control groups ( < 0.001). Plasma sGM-CSFR levels were higher in infected children than in controls, but the levels were similar between the SMA and non-SMA groups. Hemoglobin ( = -0.823, < 0.001), RBC ( = -0.852, < 0.001), HCT ( = -0.790, < 0.001) and platelets ( = -0.810, < 0.001) negatively correlated with sEPO-R. There was a strong positive correlation between sEPO-R and EPO in infected children ( = 0.901, < 0.001). Plasma sEPO-R better predicted severe anemia among malaria-infected children (cut-off point: 161.5 pg/mL, sensitivity: 96.0%, specificity: 82.9%, AUC: 0.964, < 0.001).
Conclusion: -infected children had higher plasma levels of sGM-CSFR, sEPO-R and EPO. Plasma sEPO-R correlated negatively with erythrocyte parameters, suggesting a possible contribution of the endogenous receptor to the development of severe anemia in children with malaria. Further studies to investigate the neutralizing effects of sEPO-R on erythropoietic response during malaria are recommended.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11808392 | PMC |
http://dx.doi.org/10.1002/hsr2.70460 | DOI Listing |
Biol Open
March 2025
Department of Pathology and Cell Biology, USF Health Heart Institute, University of South Florida, Tampa, FL 33602, USA.
During embryonic development vascular endothelial and hematopoietic cells are thought to originate from a common precursor, the hemangioblast. An evolutionarily conserved ETS transcription factor FLI1 has been previously implicated in the hemangioblast formation and hematopoietic and vascular development. However, its role in regulating hemangioblast transition into hematovascular lineages is still incompletely understood.
View Article and Find Full Text PDFStem Cells Dev
March 2025
Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Orchestrated changes in cell arrangements and cell-to-cell contacts are susceptible to cellular stressors during central nervous system development. Effects of mitochondrial complex I inhibition on cell-to-cell contacts have been studied in vascular and intestinal structures; however, its effects on developing neuronal cells are largely unknown. We investigated the effects of the classical mitochondrial stressor and complex I inhibitor, rotenone, on the architecture of neural rosettes-radially organized neuronal progenitor cells (NPCs)-differentiated from human-induced pluripotent stem cells.
View Article and Find Full Text PDFNeuroscientist
March 2025
Cortical Labs, Melbourne, Australia.
Harnessing intelligence from brain cells in vitro requires a multidisciplinary approach integrating wetware, hardware, and software. Wetware comprises the in vitro brain cells themselves, where differentiation from induced pluripotent stem cells offers ethical scalability; hardware typically involves a life support system and a setup to record the activity from and deliver stimulation to the brain cells; and software is required to control the hardware and process the signals coming from and going to the brain cells. This review provides a broad summary of the foundational technologies underpinning these components, along with outlining the importance of technology integration.
View Article and Find Full Text PDFTransfusion
March 2025
Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, Bern, Switzerland.
Background: Umbilical cord blood (UCB) stem cells can be collected at birth, cryopreserved, and used for transplantation in hematopoietic diseases. Typically, these stem cells are stored in public banks for allogeneic use or in private depositories for potential future utilization by the family. A proposed third option, hybrid cord blood banking, combines elements of both public and private storage.
View Article and Find Full Text PDFHaematologica
March 2025
Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan.
Mutations in the NPM1 gene (NPMc+) and in the FLT3 gene (FLT3-ITD) represent the most frequent co-occurring mutations in Acute Myeloid Leukemia (AML), yet the cellular and molecular mechanisms of their cooperation remain largely unexplored. Using mouse models that faithfully recapitulate human AML, we investigated the impact of these oncogenes on pre-leukemic and leukemic hematopoietic stem cells (HSCs), both separately and in combination. While both NPMc+ and Flt3-ITD promote the proliferation of pre-leukemia HSCs, only NPMc+ drives extended selfrenewal by preventing the depletion of the quiescent HSC pool.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!